{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:45:56Z","timestamp":1780523156313,"version":"3.54.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose of Review<\/jats:title>\n            <jats:p>Dyslipidemia can present as early as infancy however the prevalence and long-term outcomes are unclear. There is an unmet need for guidance in the evaluation and treatment approach in these patients. This review summarizes the pathophysiology of dyslipidemia in infants and toddlers and highlights potential treatment options.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent Findings<\/jats:title>\n            <jats:p>Secondary factors unique to this population including prematurity and reliance on intravenous nutrition play a role in the pathophysiology of dyslipidemia, though primary genetic causes are also recognized. Severe hypertriglyceridemia poses a risk of acute pancreatitis in an already vulnerable population. Persistent dyslipidemia is a concern for future premature cardiovascular disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Management of dyslipidemia is dependent on its etiology and severity. Primary and secondary causes should be considered and addressed. Although a variety of therapeutic agents are available in older children and adults, no approved therapies exist at this age, though off-label use of medications may be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11883-025-01305-y","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:57:31Z","timestamp":1749031051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Management of Dyslipidemia in Infants and Toddlers"],"prefix":"10.1007","volume":"27","author":[{"given":"Jennifer C.","family":"Kelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"5 Pt 2","key":"1305_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1542\/peds.80.5.789","volume":"80","author":"DS Freedman","year":"1987","unstructured":"Freedman DS, Srinivasan SR, Cresanta JL, Webber LS, Berenson GS. Cardiovascular risk factors from birth to 7 years of age: the Bogalusa heart study. Serum lipids and lipoproteins. Pediatrics. 1987;80(5 Pt 2):789\u201396.","journal-title":"Pediatrics"},{"issue":"8","key":"1305_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1203\/00006450-197808000-00011","volume":"12","author":"RR Frerichs","year":"1978","unstructured":"Frerichs RR, Srinivasan SR, Webber LS, Rieth MC, Berenson GS. Serum lipids and lipoproteins at birth in a biracial population: the Bogalusa heart study. Pediatr Res. 1978;12(8):858\u201363. https:\/\/doi.org\/10.1203\/00006450-197808000-00011.","journal-title":"Pediatr Res"},{"issue":"5","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1542\/peds.91.5.949","volume":"91","author":"MJ Kallio","year":"1993","unstructured":"Kallio MJ, Salmenpera L, Siimes MA, Perheentupa J, Miettinen TA. Tracking of serum cholesterol and lipoprotein levels from the first year of life. Pediatrics. 1993;91(5):949\u201354.","journal-title":"Pediatrics"},{"key":"1305_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2021.04.017","volume":"326","author":"LKL Oyri","year":"2021","unstructured":"Oyri LKL, Bogsrud MP, Kristiansen AL, Myhre JB, Astrup H, Retterstol K, et al. Cholesterol at ages 6, 12 and 24 months: tracking and associations with diet and maternal cholesterol in the infant cholesterol study. Atherosclerosis. 2021;326:11\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.04.017.","journal-title":"Atherosclerosis"},{"issue":"42","key":"1305_CR5","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1093\/eurheartj\/ehad547","volume":"44","author":"S Taageby Nielsen","year":"2023","unstructured":"Taageby Nielsen S, Mohr Lytsen R, Strandkjaer N, Juul Rasmussen I, Sillesen AS, Vogg ROB, et al. Significance of lipids, lipoproteins, and apolipoproteins during the first 14\u201316 months of life. Eur Heart J. 2023;44(42):4408\u201318. https:\/\/doi.org\/10.1093\/eurheartj\/ehad547.","journal-title":"Eur Heart J"},{"key":"1305_CR6","doi-asserted-by":"publisher","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular, Heart H, Blood L. I. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5(Suppl 5):S213-56. https:\/\/doi.org\/10.1542\/peds.2009-2107C","DOI":"10.1542\/peds.2009-2107C"},{"issue":"18","key":"1305_CR7","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/eurjpc\/zwac200","volume":"29","author":"SS Gidding","year":"2022","unstructured":"Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, et al. Paediatric Familial hypercholesterolaemia screening in Europe: public policy background and recommendations. Eur J Prev Cardiol. 2022;29(18):2301\u201311. https:\/\/doi.org\/10.1093\/eurjpc\/zwac200.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"1305_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1542\/peds.89.3.495","volume":"89","author":"National Cholesterol Education Program (NCEP)","year":"1992","unstructured":"National Cholesterol Education Program (NCEP). Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992;89(3):495\u2013501.","journal-title":"Pediatrics"},{"key":"1305_CR9","doi-asserted-by":"publisher","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA, \/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol. A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","DOI":"10.1161\/CIR.0000000000000625"},{"key":"1305_CR10","doi-asserted-by":"publisher","unstructured":"Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2). https:\/\/doi.org\/10.1542\/peds.2022-060640.","DOI":"10.1542\/peds.2022-060640"},{"issue":"9","key":"1305_CR11","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1210\/jc.2011-3213","volume":"97","author":"L Berglund","year":"2012","unstructured":"Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. Evaluation and treatment of hypertriglyceridemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969\u201389. https:\/\/doi.org\/10.1210\/jc.2011-3213.","journal-title":"J Clin Endocrinol Metab"},{"key":"1305_CR12","unstructured":"Linton MF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL et al. The Role of Lipids and Lipoproteins in Atherosclerosis. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, editors. Endotext. South Dartmouth (MA)2000."},{"key":"1305_CR13","doi-asserted-by":"publisher","unstructured":"Santamarina-Fojo S. The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am. 1998;27(3):551\u2013\u200967, viii. https:\/\/doi.org\/10.1016\/s0889-8529(05)70025-6","DOI":"10.1016\/s0889-8529(05)70025-6"},{"issue":"2","key":"1305_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF00231536","volume":"113","author":"MR Hayden","year":"1992","unstructured":"Hayden MR, Ma Y. Molecular genetics of human lipoprotein lipase deficiency. Mol Cell Biochem. 1992;113(2):171\u20136. https:\/\/doi.org\/10.1007\/BF00231536.","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"1305_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.5551\/jat.RV17054","volume":"28","author":"H Okazaki","year":"2021","unstructured":"Okazaki H, Gotoda T, Ogura M, Ishibashi S, Inagaki K, Daida H, et al. Current diagnosis and management of primary chylomicronemia. J Atheroscler Thromb. 2021;28(9):883\u2013904. https:\/\/doi.org\/10.5551\/jat.RV17054.","journal-title":"J Atheroscler Thromb"},{"key":"1305_CR16","unstructured":"Shah AS, Wilson DP et al. Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, editors. Endotext. South Dartmouth (MA)2000."},{"issue":"9","key":"1305_CR17","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/clinchem\/30.9.1568","volume":"30","author":"C Ehnholm","year":"1984","unstructured":"Ehnholm C, Nikkila EA, Nilsson-Ehle P. Two methods compared for measuring lipase activity in plasma after heparin administration. Clin Chem. 1984;30(9):1568\u201370.","journal-title":"Clin Chem"},{"issue":"1","key":"1305_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0021-9150(77)90021-1","volume":"27","author":"C Ehnholm","year":"1977","unstructured":"Ehnholm C, Heaf DJ, Kaijser L, Kinnunen PK, Carlson LA. Heparin-induced release of lipase activity in the human forearm: an immunological study. Atherosclerosis. 1977;27(1):35\u20139. https:\/\/doi.org\/10.1016\/0021-9150(77)90021-1.","journal-title":"Atherosclerosis"},{"issue":"16","key":"1305_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJM198904203201607","volume":"320","author":"RH Eckel","year":"1989","unstructured":"Eckel RH. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med. 1989;320(16):1060\u20138. https:\/\/doi.org\/10.1056\/NEJM198904203201607.","journal-title":"N Engl J Med"},{"issue":"5","key":"1305_CR20","doi-asserted-by":"publisher","first-page":"e96482","DOI":"10.1371\/journal.pone.0096482","volume":"9","author":"M Di Filippo","year":"2014","unstructured":"Di Filippo M, Marcais C, Charriere S, Marmontel O, Broyer M, Delay M, et al. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects. PLoS ONE. 2014;9(5):e96482. https:\/\/doi.org\/10.1371\/journal.pone.0096482.","journal-title":"PLoS ONE"},{"issue":"1","key":"1305_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ajhg.2011.11.028","volume":"90","author":"L Basel-Vanagaite","year":"2012","unstructured":"Basel-Vanagaite L, Zevit N, Har Zahav A, Guo L, Parathath S, Pasmanik-Chor M, et al. Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1. Am J Hum Genet. 2012;90(1):49\u201360. https:\/\/doi.org\/10.1016\/j.ajhg.2011.11.028.","journal-title":"Am J Hum Genet"},{"key":"1305_CR22","doi-asserted-by":"publisher","first-page":"916672","DOI":"10.3389\/fgene.2022.916672","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Sun X, Jiao L, Xiao Z, Riaz F, Zhang Y, et al. Clinical characteristics and variant analyses of transient infantile hypertriglyceridemia related to GPD1 gene. Front Genet. 2022;13:916672. https:\/\/doi.org\/10.3389\/fgene.2022.916672.","journal-title":"Front Genet"},{"issue":"3","key":"1305_CR23","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jmb.2005.12.074","volume":"357","author":"X Ou","year":"2006","unstructured":"Ou X, Ji C, Han X, Zhao X, Li X, Mao Y, et al. Crystal structures of human glycerol 3-phosphate dehydrogenase 1 (GPD1). J Mol Biol. 2006;357(3):858\u201369. https:\/\/doi.org\/10.1016\/j.jmb.2005.12.074.","journal-title":"J Mol Biol"},{"issue":"17","key":"1305_CR24","doi-asserted-by":"publisher","first-page":"e25697","DOI":"10.1097\/MD.0000000000025697","volume":"100","author":"J Wang","year":"2021","unstructured":"Wang J, Sun F, Xu P, Zhang Y, Sun X, Deng H. Transient infantile hypertriglyceridemia with jaundice: A case report. Med (Baltim). 2021;100(17):e25697. https:\/\/doi.org\/10.1097\/MD.0000000000025697.","journal-title":"Med (Baltim)"},{"issue":"2","key":"1305_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5114\/pedm.2022.116112","volume":"28","author":"S Ziolkowska","year":"2022","unstructured":"Ziolkowska S, Kijek N, Zendran I, Szuster E, Barg E. Familial hypercholesterolemia - treatment update in children, systematic review. Pediatr Endocrinol Diabetes Metab. 2022;28(2):152\u201361. https:\/\/doi.org\/10.5114\/pedm.2022.116112.","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"1305_CR26","doi-asserted-by":"publisher","first-page":"574474","DOI":"10.3389\/fgene.2020.574474","volume":"11","author":"M Vrablik","year":"2020","unstructured":"Vrablik M, Tichy L, Freiberger T, Blaha V, Satny M, Hubacek JA. Genetics of Familial hypercholesterolemia: new insights. Front Genet. 2020;11:574474. https:\/\/doi.org\/10.3389\/fgene.2020.574474.","journal-title":"Front Genet"},{"issue":"22","key":"1305_CR27","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","volume":"132","author":"SS Gidding","year":"2015","unstructured":"Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW, et al. The agenda for Familial hypercholesterolemia: A scientific statement from the American heart association. Circulation. 2015;132(22):2167\u201392. https:\/\/doi.org\/10.1161\/CIR.0000000000000297.","journal-title":"Circulation"},{"issue":"11","key":"1305_CR28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","volume":"133","author":"SD de Ferranti","year":"2016","unstructured":"de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC. Prevalence of Familial hypercholesterolemia in the 1999 to 2012 united States National health and nutrition examination surveys (NHANES). Circulation. 2016;133(11):1067\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018791.","journal-title":"Circulation"},{"issue":"2","key":"1305_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2010.11.005","volume":"214","author":"H Mabuchi","year":"2011","unstructured":"Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, et al. Molecular genetic epidemiology of homozygous Familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 2011;214(2):404\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.11.005.","journal-title":"Atherosclerosis"},{"issue":"6","key":"1305_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.5551\/jat.CR002","volume":"25","author":"M Harada-Shiba","year":"2018","unstructured":"Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, Nohara A, et al. Guidance for pediatric Familial hypercholesterolemia 2017. J Atheroscler Thromb. 2018;25(6):539\u201353. https:\/\/doi.org\/10.5551\/jat.CR002.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"1305_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.6065\/apem.2016.21.1.7","volume":"21","author":"EG Yoo","year":"2016","unstructured":"Yoo EG. Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management. Ann Pediatr Endocrinol Metab. 2016;21(1):7\u201314. https:\/\/doi.org\/10.6065\/apem.2016.21.1.7.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1","key":"1305_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12944-022-01710-1","volume":"21","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen QL, Guo S, Li YH, Li C, Zheng RJ, et al. Clinical characteristics of sitosterolemic children with Xanthomas as the first manifestation. Lipids Health Dis. 2022;21(1):100. https:\/\/doi.org\/10.1186\/s12944-022-01710-1.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"1305_CR33","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.amjcard.2020.01.048","volume":"125","author":"L Xu","year":"2020","unstructured":"Xu L, Wen W, Yang Y, Xie J, Li R, Wu Y, et al. Features of sitosterolemia in children. Am J Cardiol. 2020;125(9):1312\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2020.01.048.","journal-title":"Am J Cardiol"},{"issue":"12","key":"1305_CR34","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00431-020-03764-8","volume":"179","author":"S Rabinowicz","year":"2020","unstructured":"Rabinowicz S, Levkovitz O, Leibovitch L, Schushan-Eisen I, Morag I, Rosen C, et al. Increased risk for early hypertriglyceridemia in small for gestational age preterm infants. Eur J Pediatr. 2020;179(12):1873\u20139. https:\/\/doi.org\/10.1007\/s00431-020-03764-8.","journal-title":"Eur J Pediatr"},{"issue":"8","key":"1305_CR35","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1542\/neo.23-8-e528","volume":"23","author":"AP Chan","year":"2022","unstructured":"Chan AP, Robinson DT, Calkins KL. Hypertriglyceridemia in preterm infants. Neoreviews. 2022;23(8):e528\u201340. https:\/\/doi.org\/10.1542\/neo.23-8-e528.","journal-title":"Neoreviews"},{"issue":"2","key":"1305_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5223\/pghn.2013.16.2.116","volume":"16","author":"MS Lim","year":"2013","unstructured":"Lim MS, Choi CW, Kim BI, Yang HR. Clinical factors affecting lipid metabolism and optimal dose of heparin in preterm infants on parenteral nutrition. Pediatr Gastroenterol Hepatol Nutr. 2013;16(2):116\u201322. https:\/\/doi.org\/10.5223\/pghn.2013.16.2.116.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"6","key":"1305_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0148607186010006627","volume":"10","author":"W Park","year":"1986","unstructured":"Park W, Paust H, Brosicke H, Knoblach G, Helge H. Impaired fat utilization in parenterally fed low-birth-weight infants suffering from sepsis. JPEN J Parenter Enter Nutr. 1986;10(6):627\u201330. https:\/\/doi.org\/10.1177\/0148607186010006627.","journal-title":"JPEN J Parenter Enter Nutr"},{"issue":"2","key":"1305_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/NPM-15814099","volume":"8","author":"P Holtrop","year":"2015","unstructured":"Holtrop P, Swails T, Riggs T. Hypertriglyceridemia in extremely low birth weight infants receiving lipid emulsions. J Neonatal Perinat Med. 2015;8(2):133\u20136. https:\/\/doi.org\/10.3233\/NPM-15814099.","journal-title":"J Neonatal Perinat Med"},{"issue":"6","key":"1305_CR39","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1016\/j.clnu.2020.12.039","volume":"40","author":"I Giretti","year":"2021","unstructured":"Giretti I, D\u2019Ascenzo R, Correani A, Antognoli L, Monachesi C, Biagetti C, et al. Hypertriglyceridemia and lipid tolerance in preterm infants with a birth weight of less than 1250\u00a0g on routine parenteral nutrition. Clin Nutr. 2021;40(6):4444\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2020.12.039.","journal-title":"Clin Nutr"},{"issue":"10079","key":"1305_CR40","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/S0140-6736(17)30552-4","volume":"389","author":"JE Harding","year":"2017","unstructured":"Harding JE, Cormack BE, Alexander T, Alsweiler JM, Bloomfield FH. Advances in nutrition of the newborn infant. Lancet. 2017;389(10079):1660\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(17)30552-4.","journal-title":"Lancet"},{"issue":"4","key":"1305_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5223\/pghn.2018.21.4.234","volume":"21","author":"WW Hay","year":"2018","unstructured":"Hay WW. Jr. Nutritional support strategies for the preterm infant in the neonatal intensive care unit. Pediatr Gastroenterol Hepatol Nutr. 2018;21(4):234\u201347. https:\/\/doi.org\/10.5223\/pghn.2018.21.4.234.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"7","key":"1305_CR42","doi-asserted-by":"publisher","first-page":"151155","DOI":"10.1053\/j.semperi.2019.06.003","volume":"43","author":"KL Calkins","year":"2019","unstructured":"Calkins KL, Puder M, Gura K. The evolving use of intravenous lipid emulsions in the neonatal intensive care unit. Semin Perinatol. 2019;43(7):151155. https:\/\/doi.org\/10.1053\/j.semperi.2019.06.003.","journal-title":"Semin Perinatol"},{"issue":"1","key":"1305_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12887-018-1325-2","volume":"18","author":"R Sinclair","year":"2018","unstructured":"Sinclair R, Schindler T, Lui K, Bolisetty S. Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions. BMC Pediatr. 2018;18(1):348. https:\/\/doi.org\/10.1186\/s12887-018-1325-2.","journal-title":"BMC Pediatr"},{"issue":"5","key":"1305_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/MPG.0000000000002459","volume":"69","author":"A Correani","year":"2019","unstructured":"Correani A, Giretti I, Antognoli L, Monachesi C, Cogo P, D\u2019Ascenzo R, et al. Hypertriglyceridemia and intravenous lipid Titration during routine parenteral nutrition in small preterm infants. J Pediatr Gastroenterol Nutr. 2019;69(5):619\u201325. https:\/\/doi.org\/10.1097\/MPG.0000000000002459.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"1305_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/MOP.0000000000000607","volume":"30","author":"MC Starr","year":"2018","unstructured":"Starr MC, Hingorani SR. Prematurity and future kidney health: the growing risk of chronic kidney disease. Curr Opin Pediatr. 2018;30(2):228\u201335. https:\/\/doi.org\/10.1097\/MOP.0000000000000607.","journal-title":"Curr Opin Pediatr"},{"key":"1305_CR46","unstructured":"De La Torre A, Patni N, Wilson DP et al. Clinical Management of Dyslipidemia in Youth with Chronic Kidney Disease. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, editors. Endotext. South Dartmouth (MA)2000."},{"issue":"12","key":"1305_CR47","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2215\/CJN.03110319","volume":"14","author":"JM Saland","year":"2019","unstructured":"Saland JM, Kupferman JC, Pierce CB, Flynn JT, Mitsnefes MM, Warady BA, et al. Change in dyslipidemia with declining glomerular filtration rate and increasing proteinuria in children with CKD. Clin J Am Soc Nephrol. 2019;14(12):1711\u20138. https:\/\/doi.org\/10.2215\/CJN.03110319.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"1305_CR48","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/ki.2010.311","volume":"78","author":"JM Saland","year":"2010","unstructured":"Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, et al. Dyslipidemia in children with chronic kidney disease. Kidney Int. 2010;78(11):1154\u201363. https:\/\/doi.org\/10.1038\/ki.2010.311.","journal-title":"Kidney Int"},{"issue":"Pt 2","key":"1305_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0004563213478804","volume":"50","author":"MA Crook","year":"2013","unstructured":"Crook MA. Lipoprotein X: clinical implications. Ann Clin Biochem. 2013;50(Pt 2):93\u20134. https:\/\/doi.org\/10.1177\/0004563213478804.","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"1305_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.numecd.2018.09.006","volume":"29","author":"R Fellin","year":"2019","unstructured":"Fellin R, Manzato E. Lipoprotein-X Fifty years after its original discovery. Nutr Metab Cardiovasc Dis. 2019;29(1):4\u20138. https:\/\/doi.org\/10.1016\/j.numecd.2018.09.006.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1305_CR51","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3389\/fendo.2019.00868","volume":"10","author":"R Vukovic","year":"2019","unstructured":"Vukovic R, Zeljkovic A, Bufan B, Spasojevic-Kalimanovska V, Milenkovic T, Vekic J. Hashimoto thyroiditis and dyslipidemia in childhood: A review. Front Endocrinol (Lausanne). 2019;10:868. https:\/\/doi.org\/10.3389\/fendo.2019.00868.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"1305_CR52","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1210\/en.2009-0297","volume":"150","author":"LP Klieverik","year":"2009","unstructured":"Klieverik LP, Coomans CP, Endert E, Sauerwein HP, Havekes LM, Voshol PJ, et al. Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology. 2009;150(12):5639\u201348. https:\/\/doi.org\/10.1210\/en.2009-0297.","journal-title":"Endocrinology"},{"key":"1305_CR53","doi-asserted-by":"publisher","unstructured":"Mavromati M, Jornayvaz FR. Hypothyroidism-Associated dyslipidemia: potential molecular mechanisms leading to NAFLD. Int J Mol Sci. 2021;22(23). https:\/\/doi.org\/10.3390\/ijms222312797.","DOI":"10.3390\/ijms222312797"},{"issue":"3","key":"1305_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10545-015-9811-2","volume":"38","author":"TG Derks","year":"2015","unstructured":"Derks TG, van Rijn M. Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions. J Inherit Metab Dis. 2015;38(3):537\u201343. https:\/\/doi.org\/10.1007\/s10545-015-9811-2.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"1305_CR55","first-page":"623","volume":"100","author":"IH Lee","year":"2001","unstructured":"Lee IH, Chen HL, Jeng YM, Cheng MT, Tsao LY, Chang MH. Congenital generalized lipodystrophy in a 4-month-old infant. J Formos Med Assoc. 2001;100(9):623\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"1305_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4274\/jcrpe.galenos.2019.2019.0124","volume":"12","author":"S Ozen","year":"2020","unstructured":"Ozen S, Akinci B, Oral EA. Current diagnosis, treatment and clinical challenges in the management of lipodystrophy syndromes in children and young people. J Clin Res Pediatr Endocrinol. 2020;12(1):17\u201328. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2019.2019.0124.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"4","key":"1305_CR57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000522620","volume":"95","author":"F Mainieri","year":"2022","unstructured":"Mainieri F, Chiarelli F. Lipodystrophies in children. Horm Res Paediatr. 2022;95(4):305\u201320. https:\/\/doi.org\/10.1159\/000522620.","journal-title":"Horm Res Paediatr"},{"key":"1305_CR58","first-page":"1","volume":"228","author":"D Nguyen","year":"2015","unstructured":"Nguyen D, Kit B, Carroll M. Abnormal cholesterol among children and adolescents in the united States, 2011\u20132014. NCHS Data Brief. 2015;228:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"14","key":"1305_CR59","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa1502821","volume":"373","author":"AC Skinner","year":"2015","unstructured":"Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015;373(14):1307\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1502821.","journal-title":"N Engl J Med"},{"key":"1305_CR60","unstructured":"Herink M, Ito MK et al. Medication Induced Changes in Lipid and Lipoproteins. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, editors. Endotext. South Dartmouth (MA)2000."},{"issue":"6 Suppl","key":"1305_CR61","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","volume":"9","author":"TA Jacobson","year":"2015","unstructured":"Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, et al. National lipid association recommendations for Patient-Centered management of dyslipidemia: part 2. J Clin Lipidol. 2015;9(6 Suppl):S1\u2013e1221. https:\/\/doi.org\/10.1016\/j.jacl.2015.09.002.","journal-title":"J Clin Lipidol"},{"issue":"20","key":"1305_CR62","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","volume":"123","author":"M Miller","year":"2011","unstructured":"Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2011;123(20):2292\u2013333. https:\/\/doi.org\/10.1161\/CIR.0b013e3182160726.","journal-title":"Circulation"},{"issue":"20","key":"1305_CR63","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","volume":"124","author":"FJ Raal","year":"2011","unstructured":"Raal FJ, Pilcher GJ, Panz VR, van Deventer HE, Brice BC, Blom DJ, et al. Reduction in mortality in subjects with homozygous Familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation. 2011;124(20):2202\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.042523.","journal-title":"Circulation"},{"issue":"11","key":"1305_CR64","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","volume":"102","author":"DM Kolansky","year":"2008","unstructured":"Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Wiegers SE, et al. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous Familial hypercholesterolemia. Am J Cardiol. 2008;102(11):1438\u201343. https:\/\/doi.org\/10.1016\/j.amjcard.2008.07.035.","journal-title":"Am J Cardiol"},{"issue":"32","key":"1305_CR65","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"M Cuchel","year":"2014","unstructured":"Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al. Homozygous Familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on Familial hypercholesterolaemia of the European atherosclerosis society. Eur Heart J. 2014;35(32):2146\u201357. https:\/\/doi.org\/10.1093\/eurheartj\/ehu274.","journal-title":"Eur Heart J"},{"issue":"2","key":"1305_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1017\/s1047951102000240","volume":"12","author":"AM Al-Shaikh","year":"2002","unstructured":"Al-Shaikh AM, Abdullah MH, Barclay A, Cullen-Dean G, McCrindle BW. Impact of the characteristics of patients and their clinical management on outcomes in children with homozygous Familial hypercholesterolemia. Cardiol Young. 2002;12(2):105\u201312. https:\/\/doi.org\/10.1017\/s1047951102000240.","journal-title":"Cardiol Young"},{"issue":"5","key":"1305_CR67","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/2050640618755002","volume":"6","author":"N de Pretis","year":"2018","unstructured":"de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management. United Eur Gastroenterol J. 2018;6(5):649\u201355. https:\/\/doi.org\/10.1177\/2050640618755002.","journal-title":"United Eur Gastroenterol J"},{"issue":"20","key":"1305_CR68","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMra1505202","volume":"375","author":"CE Forsmark","year":"2016","unstructured":"Forsmark CE, Vege SS, Wilcox CM, Acute Pancreatitis. N Engl J Med. 2016;375(20):1972\u201381. https:\/\/doi.org\/10.1056\/NEJMra1505202.","journal-title":"N Engl J Med"},{"issue":"44","key":"1305_CR69","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.3748\/wjg.v12.i44.7197","volume":"12","author":"SI Gan","year":"2006","unstructured":"Gan SI, Edwards AL, Symonds CJ, Beck PL. Hypertriglyceridemia-induced pancreatitis: A case-based review. World J Gastroenterol. 2006;12(44):7197\u2013202. https:\/\/doi.org\/10.3748\/wjg.v12.i44.7197.","journal-title":"World J Gastroenterol"},{"key":"1305_CR70","doi-asserted-by":"publisher","first-page":"601915","DOI":"10.3389\/fped.2021.601915","volume":"9","author":"MY Bader","year":"2021","unstructured":"Bader MY, Lam MA, Munoz F, Thompson L, Kylat RI. Validity of random triglyceride levels in infants receiving parenteral nutrition. Front Pediatr. 2021;9:601915. https:\/\/doi.org\/10.3389\/fped.2021.601915.","journal-title":"Front Pediatr"},{"issue":"3","key":"1305_CR71","doi-asserted-by":"publisher","first-page":"31808","DOI":"10.3402\/jchimp.v6.31808","volume":"6","author":"S Melnick","year":"2016","unstructured":"Melnick S, Nazir S, Gish D, Aryal MR. Hypertriglyceridemic pancreatitis associated with confounding laboratory abnormalities. J Community Hosp Intern Med Perspect. 2016;6(3):31808. https:\/\/doi.org\/10.3402\/jchimp.v6.31808.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"1305_CR72","volume-title":"Bright futures: guidelines for health supervision of infants, children, and adolescents","author":"JF Hagan","year":"2008","unstructured":"Hagan JF, Shaw JS, Duncan PM. Bright futures: guidelines for health supervision of infants, children, and adolescents. 3rd ed. Elk Grove Village, IL.: American Academy of Pediatrics; 2008.","edition":"3"},{"issue":"6","key":"1305_CR73","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/archdischild-2020-319108","volume":"106","author":"LC Frazer","year":"2021","unstructured":"Frazer LC, Martin CR. Parenteral lipid emulsions in the preterm infant: current issues and controversies. Arch Dis Child Fetal Neonatal Ed. 2021;106(6):676\u201381. https:\/\/doi.org\/10.1136\/archdischild-2020-319108.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"1305_CR74","doi-asserted-by":"publisher","first-page":"e063","DOI":"10.1097\/PG9.0000000000000063","volume":"2","author":"AP Chan","year":"2021","unstructured":"Chan AP, Strobel KM, Calkins KL. Essential fatty acid deficiency in an extremely premature infant with intestinal failure. JPGN Rep. 2021;2(2):e063. https:\/\/doi.org\/10.1097\/PG9.0000000000000063.","journal-title":"JPGN Rep"},{"issue":"6","key":"1305_CR75","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1203\/PDR.0b013e3181bbdf2b","volume":"66","author":"SI Lee","year":"2009","unstructured":"Lee SI, Valim C, Johnston P, Le HD, Meisel J, Arsenault DA, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009;66(6):698\u2013703. https:\/\/doi.org\/10.1203\/PDR.0b013e3181bbdf2b.","journal-title":"Pediatr Res"},{"issue":"6 Pt B","key":"1305_CR76","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.clnu.2018.06.946","volume":"37","author":"A Lapillonne","year":"2018","unstructured":"Lapillonne A, Fidler Mis N, Goulet O, van den Akker CHP, Wu J, Koletzko B, et al. ESPGHAN\/ESPEN\/ESPR\/CSPEN guidelines on pediatric parenteral nutrition: lipids. Clin Nutr. 2018;37(6 Pt B):2324\u201336. https:\/\/doi.org\/10.1016\/j.clnu.2018.06.946.","journal-title":"Clin Nutr"},{"issue":"9","key":"1305_CR77","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41372-023-01637-0","volume":"43","author":"B Frost","year":"2023","unstructured":"Frost B, Martin CR, Calkins KL. Dilemmas in the delivery of intravenous lipid emulsions and approach to hypertriglyceridemia in very preterm and low birth weight infants. J Perinatol. 2023;43(9):1189\u201393. https:\/\/doi.org\/10.1038\/s41372-023-01637-0.","journal-title":"J Perinatol"},{"key":"1305_CR78","doi-asserted-by":"publisher","unstructured":"Fiorentino R, Chiarelli F. Statins in children, an update. Int J Mol Sci. 2023;24(2). https:\/\/doi.org\/10.3390\/ijms24021366.","DOI":"10.3390\/ijms24021366"},{"key":"1305_CR79","doi-asserted-by":"publisher","unstructured":"Fiorentino R, Chiarelli F. Treatment of dyslipidaemia in children. Biomedicines. 2021;9(9). https:\/\/doi.org\/10.3390\/biomedicines9091078.","DOI":"10.3390\/biomedicines9091078"},{"key":"1305_CR80","doi-asserted-by":"publisher","first-page":"e2019389","DOI":"10.1590\/1984-0462\/2021\/39\/2019389","volume":"39","author":"LM Mantovani","year":"2020","unstructured":"Mantovani LM, Pugliese C. Phytosterol supplementation in the treatment of dyslipidemia in children and adolescents: a systematic review. Rev Paul Pediatr. 2020;39:e2019389. https:\/\/doi.org\/10.1590\/1984-0462\/2021\/39\/2019389.","journal-title":"Rev Paul Pediatr"},{"key":"1305_CR81","unstructured":"Dotzel M. Food Labeling: Health Claims: Plant Sterol\/Stanol Esters and Coronary Heart Disease; Correction. Food and Drug Administration. 2000."},{"issue":"4","key":"1305_CR82","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/s41390-023-02632-z","volume":"94","author":"M Elsheikh","year":"2023","unstructured":"Elsheikh M, El Amrousy D, El-Mahdy H, Dawoud H, Harkan A, El-Barky A. Lipid profile after omega-3 supplementation in neonates with intrauterine growth retardation: a randomized controlled trial. Pediatr Res. 2023;94(4):1503\u20139. https:\/\/doi.org\/10.1038\/s41390-023-02632-z.","journal-title":"Pediatr Res"},{"issue":"1","key":"1305_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EDM-19-0052","volume":"2019","author":"SWY Poon","year":"2019","unstructured":"Poon SWY, Leung KKY, Tung JYL. Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children. Endocrinol Diabetes Metab Case Rep. 2019;2019(1):1\u20135. https:\/\/doi.org\/10.1530\/EDM-19-0052.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"1305_CR84","doi-asserted-by":"publisher","first-page":"293917","DOI":"10.1155\/2011\/293917","volume":"2011","author":"Y Rodriguez Santana","year":"2011","unstructured":"Rodriguez Santana Y, Nimo Roman A, Garcia Saez I, Lopez Alvarez JM, Consuegra Llapur E, Gonzalez Jorge R. Treatment of severe hypertriglyceridemia with continuous insulin infusion. Case Rep Crit Care. 2011;2011:293917. https:\/\/doi.org\/10.1155\/2011\/293917.","journal-title":"Case Rep Crit Care"},{"issue":"7","key":"1305_CR85","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/01.atv.17.7.1400","volume":"17","author":"M Rouis","year":"1997","unstructured":"Rouis M, Dugi KA, Previato L, Patterson AP, Brunzell JD, Brewer HB, et al. Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the Familial chylomicronemia syndrome. Arterioscler Thromb Vasc Biol. 1997;17(7):1400\u20136. https:\/\/doi.org\/10.1161\/01.atv.17.7.1400.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1305_CR86","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1542\/peds.2011-0217","volume":"129","author":"R Lutfi","year":"2012","unstructured":"Lutfi R, Huang J, Wong HR. Plasmapheresis to treat hypertriglyceridemia in a child with diabetic ketoacidosis and pancreatitis. Pediatrics. 2012;129(1):e195\u20138. https:\/\/doi.org\/10.1542\/peds.2011-0217.","journal-title":"Pediatrics"},{"issue":"12","key":"1305_CR87","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1525-1594.2009.00810.x","volume":"33","author":"C Stefanutti","year":"2009","unstructured":"Stefanutti C, Di Giacomo S, Vivenzio A, Labbadia G, Mazza F, D\u2019Alessandri G, et al. Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study. Artif Organs. 2009;33(12):1096\u2013102. https:\/\/doi.org\/10.1111\/j.1525-1594.2009.00810.x.","journal-title":"Artif Organs"},{"issue":"1","key":"1305_CR88","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jacl.2017.10.018","volume":"12","author":"S Ghoor","year":"2018","unstructured":"Ghoor S, Berlyn P, Brey N. Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure. J Clin Lipidol. 2018;12(1):243\u20135. https:\/\/doi.org\/10.1016\/j.jacl.2017.10.018.","journal-title":"J Clin Lipidol"},{"issue":"3 Suppl","key":"1305_CR89","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","volume":"5","author":"SR Daniels","year":"2011","unstructured":"Daniels SR, Gidding SS, de Ferranti SD, National Lipid Association Expert Panel on Familial H. Pediatric aspects of Familial hypercholesterolemias: recommendations from the National lipid association expert panel on Familial hypercholesterolemia. J Clin Lipidol. 2011;5(3 Suppl):S30\u20137. https:\/\/doi.org\/10.1016\/j.jacl.2011.03.453.","journal-title":"J Clin Lipidol"},{"issue":"4","key":"1305_CR90","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MOL.0b013e3283555a7e","volume":"23","author":"D Gaudet","year":"2012","unstructured":"Gaudet D, Methot J, Kastelein J. Gene therapy for lipoprotein lipase deficiency. Curr Opin Lipidol. 2012;23(4):310\u201320. https:\/\/doi.org\/10.1097\/MOL.0b013e3283555a7e.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"1305_CR91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/gt.2012.43","volume":"20","author":"D Gaudet","year":"2013","unstructured":"Gaudet D, Methot J, Dery S, Brisson D, Essiembre C, Tremblay G, et al. Efficacy and long-term safety of alipogene Tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther. 2013;20(4):361\u20139. https:\/\/doi.org\/10.1038\/gt.2012.43.","journal-title":"Gene Ther"},{"issue":"5","key":"1305_CR92","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1056\/NEJMoa1400283","volume":"373","author":"D Gaudet","year":"2015","unstructured":"Gaudet D, Alexander VJ, Baker BF, Brisson D, Tremblay K, Singleton W, et al. Antisense Inhibition of Apolipoprotein C-III in patients with hypertriglyceridemia. N Engl J Med. 2015;373(5):438\u201347. https:\/\/doi.org\/10.1056\/NEJMoa1400283.","journal-title":"N Engl J Med"},{"issue":"12","key":"1305_CR93","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1161\/ATVBAHA.122.317793","volume":"42","author":"E Bruckert","year":"2022","unstructured":"Bruckert E, Caprio S, Wiegman A, Charng MJ, Zarate-Morales CA, Baccara-Dinet MT, et al. Efficacy and safety of Alirocumab in children and adolescents with homozygous Familial hypercholesterolemia: phase 3, multinational Open-Label study. Arterioscler Thromb Vasc Biol. 2022;42(12):1447\u201357. https:\/\/doi.org\/10.1161\/ATVBAHA.122.317793.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1305_CR94","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.123.320268","author":"FJ Raal","year":"2024","unstructured":"Raal FJ, Hegele RA, Ruzza A, Lopez JAG, Bhatia AK, Wu J, et al. Arterioscler Thromb Vasc Biol. 2024;44(5):1156\u201364. https:\/\/doi.org\/10.1161\/ATVBAHA.123.320268. Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies."},{"issue":"5","key":"1305_CR95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.123.065529","volume":"149","author":"A Wiegman","year":"2024","unstructured":"Wiegman A, Greber-Platzer S, Ali S, Reijman MD, Brinton EA, Charng MJ, et al. Evinacumab for pediatric patients with homozygous Familial hypercholesterolemia. Circulation. 2024;149(5):343\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065529.","journal-title":"Circulation"},{"key":"1305_CR96","doi-asserted-by":"publisher","unstructured":"Fu Q, Hu L, Shen T, Yang R, Jiang L. Recent advances in gene therapy for Familial hypercholesterolemia: an update review. J Clin Med. 2022;11(22). https:\/\/doi.org\/10.3390\/jcm11226773.","DOI":"10.3390\/jcm11226773"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-025-01305-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:57:34Z","timestamp":1749031054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-025-01305-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1007\/s11883-025-01305-y","relation":{"references":[{"id-type":"doi","id":"10.1161\/ATVBAHA.123.320268","asserted-by":"subject"}]},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"19 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies with human or animal subjects referenced in this paper are published and follow ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"61"}}